Title: Oral and topical pharmacokinetic studies of a novel TRPV1 antagonist, PAC-14028 in rats and minipigs using liquid chromatography/tandem mass spectrometric method.
Journal: Journal of pharmaceutical and biomedical analysis 20120305
Title: Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases.
Journal: Archives of pharmacal research 20120301
Title: Antipruritic effects of TRPV1 antagonist in murine atopic dermatitis and itching models.
Journal: The Journal of investigative dermatology 20110701
Title: TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery.
Journal: Journal of dermatological science 20110401
Title: Park YH, et al. Oral and topical pharmacokinetic studies of a novel TRPV1 antagonist, PAC-14028 in rats and minipigs using liquid chromatography/tandem mass spectrometric method. J Pharm Biomed Anal. 2012 Mar 5;61:8-14.
Title: Lim KM, et al. Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases. Arch Pharm Res. 2012 Mar;35(3):393-6.
Title: Yun JW, et al. TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery. J Dermatol Sci. 2011 Apr;62(1):8-15.
